Boliden reported yet another set of clinical results. Even though performance softened sequentially on account of a severe smelter maintenance shutdown (guided earlier) and some moderation in average price realisations, the Q2 17 results were impressive. Sales were SEK11.6bn (+20% yoy; -9.2% qoq), benefiting from healthy yoy (mining) volumes and prices. Profitability was even better, with reported operating profit coming in at SEK1.9bn (+110% yoy; -11% qoq; 6% ahead of consensus). Here again,
21 Jul 2017
Strong Q2 performance
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Strong Q2 performance
Boliden reported yet another set of clinical results. Even though performance softened sequentially on account of a severe smelter maintenance shutdown (guided earlier) and some moderation in average price realisations, the Q2 17 results were impressive. Sales were SEK11.6bn (+20% yoy; -9.2% qoq), benefiting from healthy yoy (mining) volumes and prices. Profitability was even better, with reported operating profit coming in at SEK1.9bn (+110% yoy; -11% qoq; 6% ahead of consensus). Here again,